Business Standard

Ind-Swift Lab zooms 83% in seven trading days on debt settlement hope

The stock is trading at its 52-week high of Rs 67.30, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017.

Torrent Pharma, Pharma
Premium

Torrent Pharma, Pharma

SI Reporter Mumbai
Ind-Swift Laboratories is locked in upper circuit for the second straight day, up 10% at Rs 67.30, extending its six-session rally of over 60% on hopes of debt settlement.

The stock is trading at its 52-week high, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017. On comparison, the S&P BSE Sensex was up 2% during the same period.

The pharmaceutical company today said the company is in process of settlement of its debt through restructuring or OTS (one-time-settlement).

“We are at an advanced stage of the settlement with the Banks and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in